ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Clinical Practice Session

Biomarkers, Schmiomarkers: Where's the Beef?

November 06, 2021 | 10:30 AM - 12:30 PM

Location: Live-Stream, Virtual Only

Session Description

Serum creatinine measurement remains the gold standard for diagnosing AKI but has significant limitations. There has been an intensive search to identify novel biomarkers that perform better than creatinine in the diagnosis and progression of AKI. This session provides an update on the use of biomarkers in predicting AKI risk, diagnosis, prognosis, and management.

Learning Objective(s)

  • Define the role of cell-cycle arrest markers in predicting the risk of AKI and of other biomarkers in diagnosing AKI
  • Identify novel biomarkers being evaluated for their role in prognosticating the severity of AKI and in predicting renal recovery
  • Describe the pitfalls and challenges preventing biomarkers from becoming a mainstream diagnostic or prognostic tool
  • Explain how biomarkers can assist in distinguishing the distinct forms of AKI in patients with hepatorenal syndrome, thus guiding management

Learning Pathway(s)

  • Acute Kidney Injury

Moderators

  • Jorge Cerda, MD, MS, FASN
  • Sarah J. Schrauben, MD, MS

Presentations

  • Moderator's Introduction
    10:30 AM - 10:40 AM
  • Current Trends in the Use of Biomarkers to Predict and Diagnose AKI
    10:40 AM - 11:05 AM
    Sandra Kane-Gill, PharmD, MS
  • Novel Prognostic Biomarkers of AKI: Can We Predict Renal Recovery?
    11:05 AM - 11:30 AM
    Joseph H. Holthoff, MD, PhD
  • Critical Appraisal of Biomarkers in 2021: Why Are We Not There Yet?
    11:30 AM - 11:55 AM
    Jason Henry Greenberg, MD
  • Biomarkers in Cirrhosis-Associated AKI: Exploring the Etiology
    11:55 AM - 12:20 PM
    Justin Miles Belcher, MD, PhD
  • Moderator's Summary
    12:20 PM - 12:30 PM